Johanna  Roberts net worth and biography

Johanna Roberts Biography and Net Worth

EVP of Penumbra
Johanna Roberts serves as Executive Vice President, General Counsel, Secretary of the Company. She joined Penumbra in 2014. She served as Vice President and Deputy General Counsel from July 2015 until her promotion to Executive Vice President and General Counsel in September 2018. Prior to joining Penumbra, Ms. Roberts had fifteen years’ experience working for several law firms, including Morrison & Foerster LLP in San Francisco. Ms. Roberts received a B.A. from Dartmouth College and J.D. from Harvard Law School.

What is Johanna Roberts' net worth?

The estimated net worth of Johanna Roberts is at least $14.06 million as of March 1st, 2024. Ms. Roberts owns 62,997 shares of Penumbra stock worth more than $14,059,670 as of March 28th. This net worth evaluation does not reflect any other investments that Ms. Roberts may own. Additionally, Ms. Roberts receives an annual salary of $655,750.00 as EVP at Penumbra. Learn More about Johanna Roberts' net worth.

How old is Johanna Roberts?

Ms. Roberts is currently 52 years old. There are 4 older executives and no younger executives at Penumbra. The oldest executive at Penumbra is Mr. Adam Elsesser, Co-Founder, Chairman, President & CEO, who is 62 years old. Learn More on Johanna Roberts' age.

What is Johanna Roberts' salary?

As the EVP of Penumbra, Inc., Ms. Roberts earns $655,750.00 per year. The highest earning executive at Penumbra is Ms. Maggie S. Yuen, Chief Financial Officer, who commands a salary of $660,980.00 per year. Learn More on Johanna Roberts' salary.

How do I contact Johanna Roberts?

The corporate mailing address for Ms. Roberts and other Penumbra executives is One Penumbra Place, Alameda CA, 94502. Penumbra can also be reached via phone at (510) 748-3200 and via email at [email protected]. Learn More on Johanna Roberts' contact information.

Has Johanna Roberts been buying or selling shares of Penumbra?

In the last ninety days, Johanna Roberts has sold $142,608.00 of Penumbra stock. Most recently, Johanna Roberts sold 600 shares of the business's stock in a transaction on Friday, March 1st. The shares were sold at an average price of $237.68, for a transaction totalling $142,608.00. Following the completion of the sale, the executive vice president now directly owns 62,997 shares of the company's stock, valued at $14,973,126.96. Learn More on Johanna Roberts' trading history.

Who are Penumbra's active insiders?

Penumbra's insider roster includes Arani Bose (Insider), Adam Elsesser (CEO), Harpreet Grewal (Director), Don Kassing (Director), Bridget O'Rourke (Director), James Pray (Insider), Johanna Roberts (EVP), Surbhi Sarna (Director), and Thomas Wilder (Director). Learn More on Penumbra's active insiders.

Are insiders buying or selling shares of Penumbra?

In the last twelve months, insiders at the sold shares 28 times. They sold a total of 86,209 shares worth more than $24,304,275.51. The most recent insider tranaction occured on March, 4th when Director Arani Bose sold 7,500 shares worth more than $1,876,500.00. Insiders at Penumbra own 5.3% of the company. Learn More about insider trades at Penumbra.

Information on this page was last updated on 3/4/2024.

Johanna Roberts Insider Trading History at Penumbra

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/1/2024Sell600$237.68$142,608.0062,997View SEC Filing Icon  
12/1/2023Sell600$226.42$135,852.0062,251View SEC Filing Icon  
11/14/2023Sell600$214.14$128,484.0063,037View SEC Filing Icon  
10/2/2023Sell600$237.82$142,692.0063,637View SEC Filing Icon  
9/1/2023Sell600$265.11$159,066.0064,237View SEC Filing Icon  
8/14/2023Sell600$249.85$149,910.0064,837View SEC Filing Icon  
7/3/2023Sell900$340.18$306,162.0065,437View SEC Filing Icon  
6/1/2023Sell900$309.30$278,370.0066,337View SEC Filing Icon  
5/12/2023Sell1,500$319.67$479,505.0068,925View SEC Filing Icon  
4/3/2023Sell600$278.14$166,884.0069,960View SEC Filing Icon  
3/1/2023Sell600$258.62$155,172.0069,960View SEC Filing Icon  
12/1/2022Sell1,500$210.29$315,435.0055,310View SEC Filing Icon  
11/14/2022Sell1,500$194.48$291,720.0055,496View SEC Filing Icon  
10/3/2022Sell1,500$193.02$289,530.0055,496View SEC Filing Icon  
9/7/2022Sell5,800$175.17$1,015,986.0055,496View SEC Filing Icon  
8/15/2022Sell1,700$175.04$297,568.0055,496View SEC Filing Icon  
4/1/2022Sell1,500$225.32$337,980.00View SEC Filing Icon  
3/1/2022Sell1,500$225.23$337,845.00View SEC Filing Icon  
1/3/2022Sell3,250$281.57$915,102.50View SEC Filing Icon  
12/1/2021Sell1,750$246.97$432,197.50View SEC Filing Icon  
11/8/2021Sell2,500$279.21$698,025.00View SEC Filing Icon  
10/1/2021Sell2,500$261.63$654,075.00View SEC Filing Icon  
9/1/2021Sell2,500$272.02$680,050.00View SEC Filing Icon  
8/9/2021Sell2,500$263.14$657,850.0037,937View SEC Filing Icon  
8/17/2020Sell2,000$236.07$472,140.00View SEC Filing Icon  
1/30/2020Sell3,500$176.25$616,875.0022,332View SEC Filing Icon  
11/7/2018Sell1,000$150.00$150,000.00View SEC Filing Icon  
See Full Table

Johanna Roberts Buying and Selling Activity at Penumbra

This chart shows Johanna Roberts's buying and selling at Penumbra by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Penumbra Company Overview

Penumbra logo
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
Read More

Today's Range

Now: $223.18
Low: $222.71
High: $228.43

50 Day Range

MA: $248.16
Low: $220.06
High: $273.27

2 Week Range

Now: $223.18
Low: $180.93
High: $348.67

Volume

387,503 shs

Average Volume

357,772 shs

Market Capitalization

$8.64 billion

P/E Ratio

96.62

Dividend Yield

N/A

Beta

0.52